Axol Team Leader presents at global ALS conference
Axol Team Leader presents at global ALS conference Stuart Prime, Research Team Leader at Axol, recently spoke at the 2nd…
The Axol Blog
AXOL Blog
How our license with The Francis Crick Institute could de-risk drug development
How our license with The Francis Crick Institute could de-risk…
axoCellsTM Cortical Inhibitory Interneurons
Cortical Inhibitory InterneuronsInterneurons are involved in major neurological disease types.…
iPSC tech help clinic: cardiomyocytes
Ask a cardiomyocyte expert your cardiomyocyte questions! On the 26th…
‘Looking To The Future’ Program
We think they’re great ideas – but do you? As…
Celebrating World Organoid Research Day 2023
Celebrating World Organoid Research Day 2023Today we’re celebrating (and enjoying)…
“I have a simple request for you all: HURRY UP!.” Stephen Brannan
Stephen BrannanLay Member of Court, Edinburgh Napier University, and Person…
iPSC Tech Help Clinic: Microglial Cells
Ask a scientist, Microglia Tech Clinic! On 1st March, Jessica…
MPS disease models review: current status, opportunities and limitations
MPS disease models review: current status, opportunities and limitations A…
Transform in vitro assays with human iPSC-derived sensory neurons, mature in 21 days
Why are Axol’s human iPSC-derived sensory neurons transforming in vitro…
NECTAR 2022 in three minutes
Nectar 2022 The 32nd annual meeting of NECTAR (Network for…
Sensory Neurons That Behave Like Sensory Neurons
When you work with sensory neurons in vitro, you want…
Alzheimer’s Disease, genetic risk factors, and 3D models
Three recently published studies of Alzheimer’s Disease (AD) research suggest…
